Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value
.
Up to $42 Million in Two-Part Funding from New Strategic Investor and Existing Shareholders with Committed Closing of an Aggregate of $14 Million Up Front
.
MyMD Pharmaceuticals Secures Strategic Investments Up to $42 Million in Two-Part Funding from New Strategic Investor and Existing Shareholders with Committed Closing of an.
MUNICH, Germany, April 26, 2024 Sono Group N.V. , a solar technology company, today announced a correction to its press release issued on April 25, 2024, which provided an update on the.
MUNICH, Germany, April 25, 2024 Sono Group N.V. , a solar technology company, is pleased to announce a significant milestone in its corporate recovery. Following the successful conclusion of.